Archived | UCLA-led team compared DNA of children with the disorder to that of their siblings and parents | Circa August 8, 2019 #NotAnAutisticAlly

Daniel Geschwind Autism Genetic Resource Exchange (AGRE) UCLA-led team compared DNA of children with the disorder to that of their siblings and parents Marrecca Fiore | August 8, 2019 A UCLA-led research team has identified dozens of genes, including 16 new genes, that increase the risk of autism spectrum disorder. The findings, published in the journal Cell, …

Archived | Autism Speaks Portfolios: Autism Treatment | Circa 2007 #NotAnAutisticAlly

Portfolios: Autism Treatment The treatment of autism is the focus of one of four primary portfolios in the Autism Speaks Science Program. The Treatment Portfolio will focus on the areas of behavioral, biomedical and technological methods of treatment and intervention. Current and past initiatives in this area include the Innovative Technology for Autism Initiative, the Treatment Initiative and …

Archived | Autism Speaks: Autism Treatment Network | Circa 2007 #NotAnAutisticAlly

Image: Human head and shoulders silhouette with Not An Autistic Ally text and the logo for Autism Speaks Autism Treatment Network (ATN). Interactive autism network (ian) Autism Treatment Network (ATN) Autism INtervention Research Network on Physical Health Autism Treatment Network What is the ATN?  The Autism Treatment Network (ATN) is a network of treatment and …

Archived | Autism Speaks: Neural Retraining Initiative | Circa 2007 #NotAnAutisticAlly

Neural Retraining Initiative One of the most exciting stories in neuroscience in the last decade is the idea of neuroplasticity - the concept that the brain continues to grow, add new cells and change throughout life. There have been amazing breakthroughs in the treatment of stroke and dyslexia through neural retraining. Using specialized education techniques, …

Archived | Autism Speaks Portfolios: Autism Treatment Initiative & Grants | Circa 2007 #NotAnAutisticAlly

Treatment Initiative Currently there are no commonly accepted standards for autism treatment, and families are often left to navigate the course of their child's future on their own. Treatments vary regionally, and there is no system in place to coordinate the development of treatment protocols or novel therapeutics, nor their validation to qualify for insurance …

Archived | Autism Speaks: Clinical Trials Network | Circa 2007 #NotAnAutisticAlly

Clinical Trials Network Fluoxetine StudyMemantine Study Autism Speaks' Clinical Trials Network (CTN) was officially launched in 2005 by Cure Autism Now to focus on translational research, the critical step necessary to transfer findings from the laboratory to clinical application. Well controlled and appropriately blinded studies are needed to test whether anecdotal evidence holds. By facilitating …

Archived | Autism Speaks: New Developments In Autism Clinical Trials | Circa January 2004 #NotAnAutisticAlly

Download PDF d_200707_CANCONSENSUSDownload Jump to: New Developments in Autism Clinical Trials Outcome Measures for Clinical Drug Trials in Autism Subject Selection and Characterization in Clinical Trials in Children with Autism Impact of Recent Findings on Study Design of Future Autism Clinical Trials Autism Clinical Trials: Biological and Medical Issues in Patient Selection and Treatment Response …